As of 2025-07-11, the Relative Valuation of Infinity Pharmaceuticals Inc (INFI) is (25.46) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.04 USD, the upside of Infinity Pharmaceuticals Inc based on Relative Valuation is -57059.2%.
The range of the Relative Valuation is (17.65) - (26.85) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.4x - 21.3x | 17.4x |
| Forward P/E multiples | 14.0x - 32.1x | 23.0x |
| Fair Price | (17.65) - (26.85) | (25.46) |
| Upside | -39576.7% - -60161.0% | -57059.2% |
| Date | P/E |